DeutschNewstral
Article
LA Times on 2018-05-17 01:25
FDA approves Lucemyra to treat symptoms of opioid withdrawal and help patients overcome addiction
Related news
FDA Approves First Implant to Treat Opioid Addictiongizmodo.com
FDA approves non-opioid drug to treat opioid withdrawal symptomsFox News
FDA to promote use of opioid alternatives to treat addictionThe Globe and Mail
FDA approves first implantable drug to treat opioid addictionChicago Tribune
FDA Approves Trial To Treat Opioid Addiction With CBDForbes- This Device Is The First Marketed To Treat Opioid Withdrawal, But Evidence It Works Is LackingForbes
FDA chief warns about kratom to treat opioid addiction; will seek more regulatory powerUSA today
We Know How to Treat Opioid Addictionslate.com
The Wrong Way to Treat Opioid AddictionThe New York Times
Number of Babies Born With Opioid Withdrawal Symptoms Rises Sharplyinfowars.com
FDA Approves Nonopioid Treatment for Opioid Withdrawal Symptomswsj.com- TOpioid Addiction and Withdrawal: What You Should Knowtoday.uconn.edu
FDA issues warning for products marketed to treat opioid withdrawalFOX 8 News Cleveland
Doctors eye deep brain stimulation to treat opioid addictionabqjournal.com
Methadone programs help inmates treat their opioid addictionwtnh.com
Kentucky eyes ibogaine, a psychedelic, to treat opioid addictionThe Economist
Opioid addiction treatments face off in US trialKHQ Local News